Carbapenem-resistant bacteria spread in the ICU
Part of Infections clinical trials.
This study looks at how germs that resist certain antibiotics spread in the intensive care unit. It tests if the amount of these germs in a patient's body is linked to how much the room gets contaminated and how easily it infects others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the adult intensive care unit at Hospital Italiano de Buenos Aires.
- A test from your rectum has found a type of bacteria that is resistant to carbapenem antibiotics.
- You have stayed in the same ICU room for at least 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily cleansing with a special soap (chlorhexidine) combined with thoughtful use of antibiotics and stomach acid reducers can help prevent the spread of a tough germ called CPE (carbapenemase-producing Enterobacteriaceae) in the ICU. It aims to keep ICU patients safer from infection.
This study looks at certain drug-resistant bacteria in the gut of ICU patients. It aims to understand how common these bacteria are and may help guide future infection control efforts.
This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study looks at factors that make some hospitalized children in the pediatric intensive care unit (PICU) develop or carry germs called carbapenem-resistant Enterobacteriaceae. It aims to understand who is at higher risk and why, which may help prevent infections in the future.
This study will track how certain hard-to-treat bacteria spread and cause infections in people who are in the intensive care unit (ICU) or have had a stem cell transplant. The goal is to better understand and prevent these infections in vulnerable patients.
Hear when a new Healthcare-Associated Infections (HAIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.